1989
DOI: 10.1016/0306-4522(89)90383-7
|View full text |Cite
|
Sign up to set email alerts
|

Microtubule-associated protein 2 as a sensitive marker for cerebral ischemic damage—Immunohistochemical investigation of dendritic damage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

12
103
1

Year Published

1990
1990
2017
2017

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 299 publications
(116 citation statements)
references
References 18 publications
12
103
1
Order By: Relevance
“…With these conventional methods, morphological evidence of neuronal death does not become apparent until 1 to 2 hours after the onset of cerebral ischemia. However, early ischemic lesions can now be detected by applying immunohistochemical methods, and a reduction in microtubule-associated protein 2 (MAP2) immunoreactivity has been found to be an early, sensitive marker of ischemic neuronal damage [6]. In our study, by using this method, we showed that the lateral vestibular nucleus (LVe) and the ventral part of the spinal trigeminal nucleus (vSp5) were particularly vulnerable to ischemia.…”
Section: Discussionmentioning
confidence: 77%
See 1 more Smart Citation
“…With these conventional methods, morphological evidence of neuronal death does not become apparent until 1 to 2 hours after the onset of cerebral ischemia. However, early ischemic lesions can now be detected by applying immunohistochemical methods, and a reduction in microtubule-associated protein 2 (MAP2) immunoreactivity has been found to be an early, sensitive marker of ischemic neuronal damage [6]. In our study, by using this method, we showed that the lateral vestibular nucleus (LVe) and the ventral part of the spinal trigeminal nucleus (vSp5) were particularly vulnerable to ischemia.…”
Section: Discussionmentioning
confidence: 77%
“…Therefore, ischemia-induced loss of immunoreaction for MAP2 is considered to be a reliable marker of neurons that are already undergoing irreversible processes in cell death [20]. However, Kitagawa et al showed that loss of MAP2 immunostaining preceded the development of overt neuronal loss in a gerbil model of transient forebrain ischemia [6]. Our results are also consistent with this notion that MAP2 immunostaining can be used as an indicator of still viable neurons that will undergo irreversible injury only at a later time point.…”
Section: Discussionmentioning
confidence: 99%
“…6F). Loss of MAP2 has been considered as an early marker for neuronal damage following cerebral ischemia (25), spinal cord injury (26), and traumatic brain injury (27); therefore, potential toxicities of FUS G156E and FUS P525L to neurons would be reflected by reduced intensity of MAP2 immunostaining in primary neurons. In addition, primary neurons expressing HA-FUS G156E and HA-FUS P525L often exhibited abnormal cell shapes (e.g.…”
Section: Purification and Aggregation Of Gst-fus-his Proteins A Ementioning
confidence: 99%
“…T 2-weighted MRI reflects the increased water content in the edematous tissue which consist of damaged neurons and glial cells, while MAr2 immunostaining has been used for the early detection of ischemic neuronal damage (9). Therefore, it is thought that MRI reflects the decline and viability of both neurons and glias while MAr2-staining reflects those of only neurons.…”
Section: Resultsmentioning
confidence: 99%